Yanxia Lv

Yanxia Lv

Auto-generated profile, based on publicly available information

Yanxia Lv

Yongkang First People's Hospital Affiliated to Hangzhou Medical College, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2025 in Archives of Medical Science
Verified
Journal Article
Open access
MXMin Xu
Min Xu
YMYaosheng Mei
Yaosheng Mei
CLChengnan Liu
Chengnan Liu
YLYanxia Lv
Yanxia Lv
YPYifan Pan
Yifan Pan
YWYunxiang Wang
Yunxiang Wang
Introduction: Atherosclerosis is a leading cause of cardiovascular events, requiring accurate risk stratification. Traditional methods rely on subjective imaging and clinical scores, limiting precision.Material and methods: We developed a deep learning (DL) model combining U-Net for lesion segmentation, ResNet for classification, and an attention mechanism to enhance detection of high-risk plaques. Multimodal data—including ultrasound, CTA, and clinical variables—underwent standard preprocessing. The dataset was split (8:1:1) and evaluated using 5-fold cross-validation.Results: The U-Net achieved a Dice coefficient of 0.88. The ResNet, integrated with clinical features, reached 92% classification accuracy and an AUC of 0.97. The attention mechanism improved vulnerable plaque detection by 10%. Grad-CAM visualizations showed 85% agreement with expert annotations. Processing time was reduced by 70% compared to traditional assessment methods. Multicenter validation confirmed strong generalizability.Conclusions: This study constructed a multimodal DL model that significantly enhances the clinical value of atherosclerosis risk stratification, the prediction accuracy increased to 92% with an AUC of 0.97, and the average processing time per case was reduced from 6.3 ± 1.4 minutes to 1.9 ± 0.4 minutes (a reduction of approximately 70%). The model demonstrated higher precision in both lesion segmentation and high-risk plaque identification, providing clinicians with a rapid and reliable decision-support tool that is expected to further optimize individualized intervention strategies and improve patient prognosis.

1 January 2025 in Journal of Food Biochemistry
Verified
Journal Article
Open access
ZZZhenzhong Zhu
Zhenzhong Zhu
JPJunzhi Pan
Junzhi Pan
BJBin Jiang
Bin Jiang
YZYuanlong Zhang
Yuanlong Zhang
YLYanxia Lv
Yanxia Lv
WLWeijun Lv
Weijun Lv
Herbal medicine, like Polygonatum sibiricum , is gaining attention for its potential in treating myocardial ischemia. Comprehensive research on its molecular interplay is essential for its development as a therapeutic agent. The aim is to investigate the molecular mechanisms by which Polygonatum sibiricum ameliorates myocardial ischemia. The study involves a thorough database exploration, molecular docking, and the use of both in vivo and in vitro models for detailed assessment. The role of the HIF‐1α pathway is particularly emphasized. Identification of 11 principal components and 23 core proteins, with a dominant role of HIF‐1α, was achieved. A notable improvement in myocardial conditions, attributable to Polygonatum sibiricum , was observed. Polygonatum sibiricum improves myocardial ischemic injury by augmenting mitochondrial activity and enhancing the HIF‐1α pathway.